➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Dow
McKesson
McKinsey
Mallinckrodt
Johnson and Johnson
Baxter

Last Updated: August 11, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: BUPROPION HYDROBROMIDE

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

BUPROPION HYDROBROMIDE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Valeant Pharms North APLENZIN bupropion hydrobromide TABLET, EXTENDED RELEASE;ORAL 022108 NDA Bausch Health US LLC 0187-5810-07 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5810-07)
Valeant Pharms North APLENZIN bupropion hydrobromide TABLET, EXTENDED RELEASE;ORAL 022108 NDA Bausch Health US LLC 0187-5810-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5810-30)
Valeant Pharms North APLENZIN bupropion hydrobromide TABLET, EXTENDED RELEASE;ORAL 022108 NDA Bausch Health US LLC 0187-5811-07 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5811-07)
Valeant Pharms North APLENZIN bupropion hydrobromide TABLET, EXTENDED RELEASE;ORAL 022108 NDA Bausch Health US LLC 0187-5811-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5811-30)
Valeant Pharms North APLENZIN bupropion hydrobromide TABLET, EXTENDED RELEASE;ORAL 022108 NDA Bausch Health US LLC 0187-5812-07 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5812-07)
Valeant Pharms North APLENZIN bupropion hydrobromide TABLET, EXTENDED RELEASE;ORAL 022108 NDA Bausch Health US LLC 0187-5812-30 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (0187-5812-30)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Moodys
McKinsey
Merck
Baxter
Colorcon